Orin
FORMNasdaq·Semiconductors

FormFactor, Inc.

Market cap $8.3BP/E 72.2× trailingGross margin 45.6%
$106.85
+5.74 (+5.68%)Tue 27 Oct close 16:00 ET
52-wk $41.84 – $160.27
Orin's take
6out of 10 — how sure Orin is of this read

Orin's own judgment of how firmly the evidence points one way — not the chance the price goes up.

Refreshed 11 Oct, the 6th take on FORM. A new filing or a print queues the next refresh.

FormFactor's quarterly operational inflection is unmistakable—Q2 2026 revenue jumped 31.9% y/y to $258.2M with gross margin near 50.7%, and the company has posted four consecutive EPS surprises of 24% or more, driving the stock to $139.67, well above its 50-day ($119.80) and 200-day ($110.67) moving averages.

However, at 94.4x trailing earnings and 65.1x EV/EBITDA—110% above the peer median—the multiple demands flawless execution, while insiders have been relentless sellers with 91 dispositions and zero acquisitions over 24 months for net sales of $24.1M, including CEO Mike Slessor selling 17,510 shares at ~$104.73 on September 16, 2026. With Q3 2026 results due October 28th and smart money slightly negative at -0.03 as of Q2 2026, the risk/reward is balanced: the turnaround is real but largely priced in.

What could go wrong

  • Valuation compression. At 94.4x PE and 65.1x EV/EBITDA, any earnings miss or guidance cut at the October 28th Q3 report could trigger a sharp de-rating, especially with the stock already 17% above its 50-day MA.
  • Persistent insider selling. Over 24 months, insiders executed 91 dispositions and zero acquisitions for net $24.1M outflow; CEO Slessor sold at both $104 and $133 in August–September 2026, signaling no confidence-driven buying at any price level.
  • FY2025 FCF collapse. Free cash flow fell to $11.7M in FY2025 from $79.1M in FY2024 as capex surged to $103.7M; if capex remains elevated, the FCF profile may not support the premium multiple even as revenue accelerates.
  • Smart money outflows. The smart money score has been negative for three consecutive quarters, worsening from -0.02 (Q3 2025) to -0.03 (Q2 2026), despite fund count rising to 57—suggesting new holders are passive indexers rather than conviction buyers.

What would change my mind

Q3 2026 earnings beat with margin expansion. Q3 2026 revenue exceeds $270M with gross margin above 48% and EPS above $0.80, confirming the quarterly acceleration is sustainable rather than a cyclical spikebullish
Insider purchase. Any open-market acquisition by an officer or director—breaking the 24-month pattern of zero insider buys—would signal confidence at current levelsbullish
Q3 2026 miss or weak guidance. Q3 2026 revenue below $240M or FY2026 guidance implying single-digit quarterly sequential growth, which at 94x earnings would likely trigger a sharp correctionbearish
Gross margin reversion. Gross margin falls back below 42% in Q3 2026, indicating the Q2 2026 margin expansion to ~50.7% was driven by mix or one-time factors rather than structural improvementbearish

Where this comes from: Q2 FY26 results · earnings vs estimates · technicals, 9 Oct · peer comparison. Orin's read on FORM; not advice.

How has the share price moved?

27 Oct 2025 – 27 Oct 2026

Up 144% over twelve months, from $43.77 on 27 Oct 2025 to $106.85 at the Tue 27 Oct 2026 close. Its highest close in that time was $159.93 on 30 Jun 2026; the last close is 33.2% below it.

Jan 2026AprJulOct
    • Green line: the closing price each trading day.
    • Grey line: the average closing price over the last 50 trading days.
    • Dashed amber line: the same over the last 200 trading days — a slower, smoother line.
    • Bars along the bottom: shares traded each day — green when it closed higher than the day before, rose when lower (the most, 13.9M, on 5 Oct 2026).
    • Flags: the company's filings, on the day they were made (a 10-Q is the quarterly report and a 10-K the annual report; an 8-K reports a major event).

    Largest holders · 13F Q2 2026

    Money flow
    FilerPositionOf fund
    BlackRock$1.7B0.0%
    Vanguard Portfolio Management$838.4M0.0%
    Earnest Partners$601.9M2.2%
    Vanguard Capital Management$562.2M0.0%
    State Street$412.9M0.0%
    Geode Capital Management$294.5M0.0%
    Bank of America$285.3M0.0%
    Invesco$252.5M0.0%
    Norges Bank$163.8M0.0%
    Morgan Stanley$143.9M0.0%

    79 of the 815 filers we track · quarter ended Q2 2026 · positions, not flows

    Insiders, last 24 months: 232 Form 4 filings; open-market trades net −$25.0M. Of the 50 on hand, 0 were open-market purchases and 28 sales — the rest are grants, option exercises and tax withholding.

    Ask Orin about FORM

    its filings · its transcripts · its numbers

    Orin answers questions about FORM from its filings, transcripts and numbers — with the source behind every claim. Your own desk starts with 3 free days, card required.

    Start 3 free days →

    How is it priced, against its own past and its sector?

    Tue 27 Oct close

    Priced at 72.2× its last 12 months of profit (Tue 27 Oct close) — higher than in 4 of its last 5 fiscal years (middle 42.3×); the typical Technology company on the NASDAQ is at 46.1×.

    MeasureNowIts usualSector
    P/E72.2×above usual42.3×46.1×
    P/S9.25×above usual4.65×—
    EV/EBITDA49.8×above usual24.4×—
    P/B7.5×above usual3.7×—
    • "Its usual" is the middle of its own last 5 fiscal years.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    P/S: the company's total market value divided by one year of revenue. Used when there is no profit to measure.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    P/B: the share price divided by the book value per share — what the company owns minus what it owes, as its accounts record it. When book value is tiny, P/B swings wildly and says little.

    What do the analysts who cover it publish?

    8 firms rated it in the last 18 months · 27 Oct

    The analysts' average 12-month price target is $151 (from $115 to $200) — 42% above the Tue 27 Oct close price. That is their published opinion, not Orin's.

    Average price target

    $151

    $115 – $200 · +42% against the last close

    Their ratings
    • 5 buy or overweight
    • 3 hold
    • 0 underweight or sell

    Price target: the share price an analyst publishes for about 12 months ahead. It is the opinion of the firm that wrote it; the average is across the firms that cover the company.

    Overweight / underweight: analysts' rating words: overweight means the firm expects the stock to do better than the others it covers, underweight worse. Their words, not Orin's.

    How is it priced next to the companies it is compared to?

    2 of 4 with a profit

    Priced at 72.2× its last 12 months of profit. Only 2 of the 4 companies it is compared to made a profit (INTT 96.4×, TER 44.2×), so there is no typical P/E.

    CompanyMarket valueP/EEV/EBITDAGross marginNet marginROE
    FORMFormFactor, Inc.$8B72.2×49.8×45.6%12.8%11%
    AEHRAehr Test Systems$2Blost moneyn/m34.7%−14.0%−5%
    COHUCohu, Inc.$2Blost money118×39.2%−7.4%−5%
    INTTinTEST Corporation$158M96.4×17.8×42.7%1.2%2%
    TERTeradyne, Inc.$51B44.2×33.1×59.2%25.8%38%
    • AEHR, COHU: lost money over the last 12 months, so no P/E.
    • AEHR: EV/EBITDA is not meaningful (n/m) — its cash exceeds its market value plus debt, or the business lost money before depreciation.
    • The list of companies is the data vendor's choice, so it can include a company a person would not have picked.

    Market value: the share price times the number of shares — what the whole company is priced at.

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    EV/EBITDA: the price of the whole company (its shares plus its debt, minus its cash) divided by one year of operating profit before interest, tax and write-downs.

    Gross margin: the share of each $1 of sales left after the direct cost of making what was sold.

    Net margin: the share of each $1 of sales kept as profit after every cost. Below zero, the company lost money.

    ROE: return on equity: one year of profit as a share of the shareholders' money in the business (its book value).

    Is it priced high or low compared with its own past?

    Tue 27 Oct

    Priced at 72.2× its last 12 months of profit (Tue 27 Oct close). It has no full fiscal year on file since its history starts, so there is nothing of its own to compare with.

    • Now72.2×

    P/E: the share price divided by one year of profit per share — roughly how many years of today's profit the price pays for. A company that loses money has no P/E.

    Fiscal year (FY): the company's own 12-month accounting year, which need not match the calendar year.

    How has its sector been priced?

    Now–Now · Tue 27 Oct

    Technology companies on the NASDAQ were priced at a typical 46.1× their yearly profit (Tue 27 Oct close).

    • Now46.1×
    • Each year is the middle of that calendar year's daily sector P/E; "Now" is the Tue 27 Oct close figure, the same one in the table above.

    Sector P/E: the middle P/E of the companies in the same sector on the same stock exchange, as the data vendor works it out each day.

    What does a cash-flow model say a share is worth?

    computed 27 Oct at $106.87

    A standard cash-flow model puts it at $9 a share — 92% below the $106.87 price it was computed against (27 Oct).

    ModelValue a shareAgainst the price then
    Standard$992% below $106.87
    Levered$1091% below $106.87

    Discounted cash flow: a model's estimate of what the company is worth today, from the cash it is forecast to make in future years. Small changes in the forecast move it a lot, and it says little about a company that loses money.

    Standard / levered: two versions of the cash-flow model: the standard one counts the cash before the company pays its lenders, the levered one after.